Secondary Logo

About the Journal

The European Journal of Oncology Pharmacy is a peer-reviewed pharmaceutical journal in the field of cancer treatment. This Scientific Journal focuses on all the aspects of pharmacy oriented to cancer. It is the official journal of the European Society of Oncology Pharmacy.


This journal encompasses all the recent issues related to the role of pharmacists in the prevention and treatment of cancers under its scope. This includes basic and applied researches on the synthesis or extraction, compounding, analysis, stability, pharmacology, side-effects and clinical use of anticancer drugs and adjuvants therapies such as antiemetic, analgesic or complementary medicines. The Journal will be interested in featuring articles discussing the multi- professional approaches of patient care.

Authors are encouraged to share their ideas and valuable research outcomes through this Journal and provide the global readers updated and most important information in the mode of original articles, review articles, case reports, short communications, etc. Top quality articles are expected from the global research community which will aid in achieving high impact factor and largest diffusion.

This scientific journal is using Editorial Manager System for quality in the peer review process. Review processing is performed by the editorial board members of European Journal of Oncology Pharmacy or outside experts; at least two independent reviewers' approval followed by editor's approval is required for acceptance of any citable manuscript.

Publication & Editorial Staff Contacts

Publisher
Mike Richards
michael.richards@wolterskluwer.com

Wolters Kluwer
Citi Building, 41st Floor,
25 Canada Square, Canary Wharf
London, E14 5LQ,
United Kingdom
+44 (0)203-197-6615

Editor-in-Chief
Alain Astier
Groupe Hospitalo-universitaire Henri Mondor
Université Paris 12,
Créteil, France

Production Editor
Vanessa Hairfield
vanessa.hairfield@wolterskluwer.com